Abstract
Exosomes are nanosized vesicles, released by various cells, which have essential roles in intercellular communication locally and systemically through transporting their contents such as proteins and lipids as well as RNA. It was clear that the element of contents in exosomes reassembled with the emerging of cancers. Over the past decade, researchers paid more attention to the role of exosomes in breast cancer. The purpose of this review was to discuss the details of the biological characteristics of exosomes in breast cancer. The discussion would focus on the role of exosomes in breast cancer development, progression, metastasis and drug resistance, as well as related therapeutic and diagnostic strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. Cancer J Clin 2015; 65: 87–108.
Fan L, Strasser-Weippl K, Li J-J St, Louis J, Finkelstein DM, Yu K-D et al. Breast cancer in China. Lancet Oncol 2014; 15: e279–e289.
Kruger S, Abd Elmageed ZY, Hawke DH, Worner PM, Jansen DA, Abdel-Mageed AB et al. Molecular characterization of exosome-like vesicles from breast cancer cells. BMC Cancer 2014; 14: 44.
Harris DA, Patel SH, Gucek M, Hendrix A, Westbroek W, Taraska JW . Exosomes released from breast cancer carcinomas stimulate cell movement. PLoS One 2015; 10: e0117495.
Pan BT, Teng K, Wu C, Adam M, Johnstone RM . Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985; 101: 942–948.
Yu B, Zhang X, Li X . Exosomes derived from mesenchymal stem cells. Int J Mol Sci 2014; 15: 4142–4157.
Lorraine OD . Expanding on exosomes and ectosomes in cancer. N Engl J Med 2015; 372: 2359–2362.
Ferguson SW, Nguyen J . Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J Control Rel 2016; 228: 179–190.
ELA S, Mager I, Breakefield XO, Wood MJ . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013; 12: 347–357.
Vlassov AV, Magdaleno S, Setterquist R, Conrad R . Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820: 940–948.
Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569–579.
Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H . Exosomes derived from Epstein–Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol 2013; 87: 10334–10347.
Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GA . Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ 2015; 22: 34–45.
Gupta A, Pulliam L . Exosomes as mediators of neuroinflammation. J Neuroinflamm 2014; 11: 68.
Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S . Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 2015; 15: 260–271.
Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003; 278: 10963–10972.
Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001; 166: 7309–7318.
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654–659.
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010; 107: 6328–6333.
Mathivanan S, Simpson RJ . ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009; 9: 4997–5000.
Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183: 1161–1172.
Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ . Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010; 190: 1079–1091.
Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009; 20: 363–379.
Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010; 116: 2385–2394.
Chiba M, Kimura M, Asari S . Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 2012; 28: 1551–1558.
Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470–1476.
Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001; 7: 297–303.
Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 2009; 278: 73–81.
Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J . Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 2007; 120: 90–102.
Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883–891.
Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 2010; 5: e15573.
Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010; 138: 949–57 e1-7.
Lau CS, Wong DT . Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 2012; 7: e33037.
Khan S, Bennit HF, Turay D, Perez M, Mirshahidi S, Yuan Y et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014; 14: 176.
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015; 523: 177–182.
Roberg-Larsen H, Lund K, Seterdal KE, Solheim S, Vehus T, Solberg N et al. Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes. J Steroid Biochem Mol Biol 2016 (doi: 10.1016/j.jsbmb.2016.02.006; e-pub ahead of print).
Zhang HG, Cao P, Teng Y, Hu X, Wang Q, Yeri AS et al. Isolation, identification, and characterization of novel nanovesicles. Oncotarget 2016; 7: 41346–41362.
Rodriguez M, Silva J, Herrera A, Herrera M, Pena C, Martin P et al. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer. Oncotarget 2015; 6: 40575–40587.
Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B et al. Mitochondrial reprogramming regulates breast cancer progression. Clin Cancer Res 2016; 22: 3348–3360.
Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25: 501–515.
Yang M, Chen J, Su F, Yu B, Su F, Lin L et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011; 10: 117.
Singh R, Pochampally R, Watabe K, Lu Z, Mo YY . Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer 2014; 13: 256.
Shi J, Ren Y, Zhen L, Qiu X . Exosomes from breast cancer cells stimulate proliferation and inhibit apoptosis of CD133+ cancer cells in vitro. Mol Med Rep 2015; 11: 405–409.
Lin R, Wang S, Zhao RC . Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem 2013; 383: 13–20.
Dutta S, Warshall C, Bandyopadhyay C, Dutta D, Chandran B . Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One 2014; 9: e97580.
Gorczynski RM, Erin N, Zhu F . Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor. Cancer Med 2016; 5: 325–336.
Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151: 1542–1556.
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One 2014; 9: e95240.
Chen WX, Cai YQ, Lv MM, Chen L, Zhong SL, Ma TF et al. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol 2014; 35: 9649–9659.
Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys JM, Davey R et al. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J 2012; 26: 420–429.
Yu DD, Wu Y, Zhang XH, Lv MM, Chen WX, Chen X et al. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Tumour Biol 2016; 37: 3227–3235.
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 2014; 159: 499–513.
Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma TF et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol 2014; 35: 10773–10779.
Gradishar WJ . Tamoxifen—what next? Oncologist 2004; 9: 378–384.
Overmoyer B . Treatment with adjuvant endocrine therapy for early-stage breast cancer: is it forever? J Clin Oncol 2015; 33: 823–828.
Feng QJ, Zhang F, Huang XY, Wu ZX . Effectiveness and complications of anthracycline and taxane in the therapy of breast cancer: a meta-analysis. Pathol Oncol Res 2014; 20: 179–184.
Koido S, Homma S, Takahara A, Namiki Y, Tsukinaga S, Mitobe J et al. Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol 2011; 2011: 267539.
Rieger J, Freichels H, Imberty A, Putaux JL, Delair T, Jerome C et al. Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 2009; 10: 651–657.
Cho JA, Yeo DJ, Son HY, Kim HW, Jung DS, Ko JK et al. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer 2005; 114: 613–622.
Tan A, De La Pena H, Seifalian AM . The application of exosomes as a nanoscale cancer vaccine. Int J Nanomed 2010; 5: 889–900.
Mahmoodzadeh Hosseini H, Imani Fooladi AA, Soleimanirad J, Nourani MR, Davaran S, Mahdavi M . Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells. Tumour Biol 2014; 35: 3699–3707.
Rong L, Li R, Li S, Luo R . Immunosuppression of breast cancer cells mediated by transforming growth factor-beta in exosomes from cancer cells. Oncol Lett 2016; 11: 500–504.
Ishida T, Kiwada H . Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int J Pharm 2008; 354: 56–62.
Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014; 35: 2383–2390.
Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013; 21: 185–191.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wu, CY., Du, SL., Zhang, J. et al. Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Cancer Gene Ther 24, 6–12 (2017). https://doi.org/10.1038/cgt.2016.69
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2016.69
This article is cited by
-
Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases
Cell Communication and Signaling (2024)
-
Anaplasma phagocytophilum Ats-1 enhances exosome secretion through Syntenin-1
BMC Microbiology (2023)
-
Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer
Scientific Reports (2023)
-
An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer
Scientific Reports (2022)
-
Platelet-derived exosomes promote the epithelial–mesenchymal transition in MCF7 cells
Molecular & Cellular Toxicology (2022)